166 related articles for article (PubMed ID: 6088469)
1. The role of the National Institute on Drug Abuse in the development of naltrexone.
Ginzburg HM; Glass WJ
J Clin Psychiatry; 1984 Sep; 45(9 Pt 2):4-6. PubMed ID: 6088469
[TBL] [Abstract][Full Text] [Related]
2. Naltrexone in addicted physicians and business executives.
Washton AM; Gold MS; Pottash AC
NIDA Res Monogr; 1984; 55():185-90. PubMed ID: 6443377
[TBL] [Abstract][Full Text] [Related]
3. Naltrexone in addicted business executives and physicians.
Washton AM; Pottash AC; Gold MS
J Clin Psychiatry; 1984 Sep; 45(9 Pt 2):39-41. PubMed ID: 6088468
[TBL] [Abstract][Full Text] [Related]
4. Clonidine hydrochloride detoxification from methadone treatment--the value of naltrexone aftercare.
Rawson RA; Washton AM; Resnick RB; Tennant FS
Adv Alcohol Subst Abuse; 1984; 3(3):41-9. PubMed ID: 6093484
[TBL] [Abstract][Full Text] [Related]
5. The sequential use of clonidine and naltrexone in the treatment of opiate addicts.
Gold MS; Dackis CA; Washton AM
Adv Alcohol Subst Abuse; 1984; 3(3):19-39. PubMed ID: 6388273
[TBL] [Abstract][Full Text] [Related]
6. Successful use of naltrexone in addicted physicians and business executives.
Washton AM; Gold MS; Pottash AC
Adv Alcohol Subst Abuse; 1984; 4(2):89-96. PubMed ID: 6524509
[TBL] [Abstract][Full Text] [Related]
7. [Detoxication in opiate addiction and prevention of recurrence: administration of naltrexone and cognitive behavior therapy].
Roozen HG; Deden AL; Kerkhof AJ; Vorsteveld JP; van den Brink W
Ned Tijdschr Geneeskd; 1997 Dec; 141(49):2377-80. PubMed ID: 9554156
[TBL] [Abstract][Full Text] [Related]
8. Clinical evaluation of naltrexone treatment of opiate-dependent individuals. Report of the National Research Council Committee on Clinical Evaluation of Narcotic Antagonists.
Arch Gen Psychiatry; 1978 Mar; 35(3):335-40. PubMed ID: 365122
[TBL] [Abstract][Full Text] [Related]
9. Effectiveness of low-dose naltrexone in the post-detoxification treatment of opioid dependence.
Mannelli P; Patkar AA; Peindl K; Murray HW; Wu LT; Hubbard R
J Clin Psychopharmacol; 2007 Oct; 27(5):468-74. PubMed ID: 17873678
[TBL] [Abstract][Full Text] [Related]
10. Opiate addiction and the locus coeruleus. The clinical utility of clonidine, naltrexone, methadone, and buprenorphine.
Gold MS
Psychiatr Clin North Am; 1993 Mar; 16(1):61-73. PubMed ID: 8456048
[TBL] [Abstract][Full Text] [Related]
11. Naltrexone induction: psychologic and pharmacologic strategies.
Kleber HD; Kosten TR
J Clin Psychiatry; 1984 Sep; 45(9 Pt 2):29-38. PubMed ID: 6469934
[TBL] [Abstract][Full Text] [Related]
12. Naltrexone treatment for addicted health-care professionals: a collaborative private practice experience.
Ling W; Wesson DR
J Clin Psychiatry; 1984 Sep; 45(9 Pt 2):46-8. PubMed ID: 6469936
[TBL] [Abstract][Full Text] [Related]
13. [Ultra-rapid detoxification of opiate dependent patients: review of the literature, critiques and proposition for an experimental protocol].
Fontaine E; Godfroid IO; Guillaume R
Encephale; 2001; 27(2):187-93. PubMed ID: 11407272
[TBL] [Abstract][Full Text] [Related]
14. Clonidine and opiate receptor antagonists in the treatment of heroin addiction.
Gerra G; Marcato A; Caccavari R; Fontanesi B; Delsignore R; Fertonani G; Avanzini P; Rustichelli P; Passeri M
J Subst Abuse Treat; 1995; 12(1):35-41. PubMed ID: 7752296
[TBL] [Abstract][Full Text] [Related]
15. Naltrexone treatment in a jail work-release program.
Brahen LS; Henderson RK; Capone T; Kordal N
J Clin Psychiatry; 1984 Sep; 45(9 Pt 2):49-52. PubMed ID: 6469937
[TBL] [Abstract][Full Text] [Related]
16. Outpatient treatment engagement and abstinence rates following inpatient opioid detoxification.
Davison JW; Sweeney ML; Bush KR; Davis Correale TM; Calsyn DA; Reoux JP; Sloan KL; Kivlahan DR
J Addict Dis; 2006; 25(4):27-35. PubMed ID: 17088223
[TBL] [Abstract][Full Text] [Related]
17. Review of naltrexone, a long-acting opiate antagonist.
Crabtree BL
Clin Pharm; 1984; 3(3):273-80. PubMed ID: 6329589
[TBL] [Abstract][Full Text] [Related]
18. [Limited role of naltrexone in the treatment of opiate addiction].
van Brussel GH
Ned Tijdschr Geneeskd; 2001 Jul; 145(30):1452-6. PubMed ID: 11503313
[TBL] [Abstract][Full Text] [Related]
19. Ultra-rapid opiate detoxification followed by nine months of naltrexone maintenance therapy in Iran.
Naderi-Heiden A; Naderi A; Naderi MM; Rahmani-Didar F; Salimi AR; Gleiss A; Kasper S; Frey R
Pharmacopsychiatry; 2010 Jun; 43(4):130-7. PubMed ID: 20101570
[TBL] [Abstract][Full Text] [Related]
20. Naltrexone: its clinical utility.
Ginzburg HM
Adv Alcohol Subst Abuse; 1985 Fall-1986 Winter; 5(1-2):83-101. PubMed ID: 3832903
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
